Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001070081-25-000028
Filing Date
2025-11-04
Accepted
2025-11-04 16:33:24
Documents
97
Period of Report
2025-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q tmb-20250930x10q.htm   iXBRL 10-Q 3062270
2 EX-10.1 tmb-20250930xex10d1.htm EX-10.1 168459
3 EX-31.1 tmb-20250930xex31d1.htm EX-31.1 10825
4 EX-31.2 tmb-20250930xex31d2.htm EX-31.2 10636
5 EX-32.1 tmb-20250930xex32d1.htm EX-32.1 5851
6 EX-32.2 tmb-20250930xex32d2.htm EX-32.2 6041
  Complete submission text file 0001070081-25-000028.txt   15060552

Data Files

Seq Description Document Type Size
7 EX-101.SCH tmb-20250930.xsd EX-101.SCH 90034
8 EX-101.CAL tmb-20250930_cal.xml EX-101.CAL 89141
9 EX-101.DEF tmb-20250930_def.xml EX-101.DEF 388159
10 EX-101.LAB tmb-20250930_lab.xml EX-101.LAB 795529
11 EX-101.PRE tmb-20250930_pre.xml EX-101.PRE 607547
100 EXTRACTED XBRL INSTANCE DOCUMENT tmb-20250930x10q_htm.xml XML 3337118
Mailing Address 500 WARREN CORPORATE CENTER DRIVE WARREN NJ 07059
Business Address 500 WARREN CORPORATE CENTER DRIVE WARREN NJ 07059 9082227000
PTC THERAPEUTICS, INC. (Filer) CIK: 0001070081 (see all company filings)

EIN.: 043416587 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35969 | Film No.: 251449724
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)